Enteric Disease Testing Market Analysis, By Disease Type (Bacterial (C. Difficile, Cholera, E. Coli, H. Pylori, Salmonellosis, Shigellosis), Viral (Rotavirus, Norovirus), Parasitic (Amebiasis, Cryptosporidiosis, Giardiasis), And Segment Forecasts, 2014 - 2025

Published: Aug, 2017 | Pages: 90 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global enteric disease testing market is expected to reach USD 4.2 billion by 2025 according to a new study by Grand View Research Inc. Increasing demand for rapid diagnosis in order to treat diseases such as cholera, and other diarrheal diseases, rise in the aging population accompanied with unhygienic living conditions and growing application of medical testing for enteric diseases are expected to drive the market over the forecast period.

The growth is further attributed to rising healthcare expenditure, supportive government initiatives, and augmenting disease prevalence rate.Economic and environmental factors such as poor sanitation and rising population living below the poverty line with no access to hygienic food and water supply are attributed to growing incidence rate of the infections and thus propel the market growth.

According to database of Bill and Melinda Gate Foundation, enteric diseases were responsible for about 500,000 deaths each year and these are anticipated to increase further. The highest mortality rate was observed amongst people above 75 years of age followed by children under 5 year of age.

Strategic initiatives by healthcare federal bodies such as the WHO and UNICEF, to manage the disease fatality effectively are expected to assist market growth. These agencies are working towards promoting widespread testing of people for such infections by conducting awareness programmes and healthcare camps. They also fund local agencies in third world countries to limit the spread of these infections.

Further Key Findings from the Study Suggest:

• Bacterial enteric disease testing market is expected to dominate the market in 2025 with revenue share of over 60.32% in 2016 due to higher occurrence of these infections. According to research conducted by Johns Hopkins Bloomberg School of Public Health, around four to six million people die annually due to bacterial infection induced diarrhea.

• Parasitic enteric disease testing market is expected to register significant growth with CAGR of 1.9%. The WHO has estimated over 200 million people to be infected annually by parasites such as giardia lamblia, cryptosporidium and E. histolytica.

• North American region is anticipated to contribute for 26.55% revenue in 2025, owing to rising geriatric population base, increasing number of immigrants, and rising patient awareness levels coupled with relatively higher healthcare expenditures in the region.

• Asia Pacific region is projected to reach over USD 1.0 billion by registering lucrative growth rate in 2025. Government efforts in countries such as Japan, China, and India to increase awareness and promote higher testing are expected to drive the market over the forecast period.

• Major market players are Alere Inc., Quest Diagnostics, Becton Dickinson & Company, bioMerieux, Bio-Rad Laboratories and Cepheid.

• Industry players are constantly fueling the market with new product launches or upgrading the existing technology. In January 2015, Biomerica filed a patent application with the U.S. Patent and Trademark Office for a test used in detection of gastrointestinal disorder.

• Apart from technology innovation, many industry players are collaborating to use each other's strength and are formulating strategic alliances in order to incur higher profits. For instance, in May 2017, Quest diagnostics announced collaboration with PeaceHealth to enhance the service through high value design and innovation.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. Enteric Disease Testing - Industry Summary and Key Buying Criteria, 2014 - 2025
Chapter 3. Enteric Disease Testing Industry Outlook
3.1. Enteric disease testing market segmentation
3.2. Enteric disease testing market size and growth prospects, 2014-2025
3.3. Enteric disease testing market dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Key opportunities prioritized
3.5. Industry analysis - Porter's
3.6. Enteric disease testing market PESTEL analysis, 2014
Chapter 4. Enteric Disease Testing Disease Type Outlook
4.1. Enteric disease testing market share by disease type, 2014 & 2025
4.2. Bacterial enteric disease market estimates and forecasts, 2014 - 2025 (USD Million)
4.2.1. C. difficile
4.2.2. Campylobacteriosis
4.2.3. Cholera
4.2.4. E.Coli
4.2.5. H.Pylori
4.2.6. Salmonellosis
4.2.7. Shigellosis
4.3. Viral enteric disease estimates and forecasts, 2014 - 2025 (USD Million)
4.3.1. Rotavirus
4.3.2. Norovirus
4.4. Parasitic enteric disease market estimates and forecasts, 2014 - 2025 (USD Million)
4.4.1. Amebiasis
4.4.2. Cryptosporidiosis
4.4.3. Giardiasis
Chapter 5. Enteric Disease Testing Regional Outlook
5.1. North America
5.1.1. North America market, by disease type, 2014 - 2025 (USD Million)
5.2. Europe
5.2.1. Europe market, by disease type, 2014 - 2025 (USD Million)
5.3. Asia Pacific
5.3.1. Asia Pacific market, by disease type, 2014 - 2025 (USD Million)
5.4. Latin America
5.4.1. Latin America market, by disease type, 2014 - 2025 (USD Million)
5.5. MEA
5.5.1. MEA market, by disease type, 2014 - 2025 (USD Million)
Chapter 6. Competitive Landscape
6.1. Alere Inc.
6.1.1. Company Overview
6.1.2. Financial Performance
6.1.3. Product Benchmarking
6.1.4. Strategic Initiatives
6.2. Becton, Dickinson & Company
6.2.1. Company Overview
6.2.2. Financial Performance
6.2.3. Product Benchmarking
6.2.4. Strategic Initiatives
6.3. Biomerica Inc.
6.3.1. Company Overview
6.3.2. Financial Performance
6.3.3. Product Benchmarking
6.3.4. Strategic Initiatives
6.4. bioMerieux
6.4.1. Company Overview
6.4.2. Financial Performance
6.4.3. Product Benchmarking
6.4.4. Strategic Initiatives
6.5. Bio Rad Laboratories
6.5.1. Company Overview
6.5.2. Financial Performance
6.5.3. Product Benchmarking
6.5.4. Strategic Initiatives
6.6. Cepheid
6.6.1. Company Overview
6.6.2. Financial Performance
6.6.3. Product Benchmarking
6.6.4. Strategic Initiatives
6.7. Coris BioConcept
6.7.1. Company Overview
6.7.2. Financial Performance
6.7.3. Product Benchmarking
6.7.4. Strategic Initiatives
6.8. DiaSorin
6.8.1. Company Overview
6.8.2. Financial Performance
6.8.3. Product Benchmarking
6.8.4. Strategic Initiatives
6.9. Meridian BioSceinces
6.9.1. Company Overview
6.9.2. Financial Performance
6.9.3. Product Benchmarking
6.9.4. Strategic Initiatives
6.10. Quest Diagnostics
6.10.1. Company Overview
6.10.2. Financial Performance
6.10.3. Product Benchmarking
6.10.4. Strategic Initiatives

List of Tables

1. Enteric disease testing - Industry Snapshot
2. Enteric disease testing market, by product, 2014 - 2025 (USD million)
3. Enteric disease testing market , by region, 2014 - 2025 (USD million)
4. Enteric disease testing market - Key market drivers analysis
5. Enteric disease testing market - Key market restraints analysis
6. North America Enteric disease testing market , by type, 2014 - 2025 (USD million)
7. Europe enteric disease testing market , by type, 2014 - 2025 (USD million)
8. Asia Pacific enteric disease testing market , by type, 2014 - 2025 (USD million)
9. Latin America enteric disease testing market , by type, 2014 - 2025 (USD million)
10. MEA enteric disease testing market , by type, 2014 - 2025 (USD million)